Clinical Trials · NCT03043807
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 26
- Start date
- Feb 2017
- Locations
- 2 sites, United States
- Primary endpoint
- Efficacy as Assessed by 3-year Prostate-specific Antigen Progression-free Survival Rate